FDA reviews cardiac risk of Invirase in combination with Norvir - MPR
Links shared publicly online about this topic.
- 1,360total visits
FDA reviews cardiac risk of Invirase in combination with Norvir - MPR
empr.com —
View full resource at empr.com
Tags: Heart, HIV Medication, Healthcare, Clinical Trial, FDA, Norvir, Invirase
Most Recently Shared on February 23, 2010 at 9:07 pm By:
MPR News: FDA reviews cardiac risk of Invirase in combination with Norvir: The FDA has notified healthcare profess... http://bit.ly/bNJGxD
Symposier - Review of HIV medication Invirase (saquinavir) and Cardiac Arrhythmias
symposier.com — “Uploaded and Shared in Youtube by: USFoodandDrugAdmin FDA is reviewing clinical trial data suggesting that using Invirase (saquinavir) in combination with Norvir (ritonavir) may increase the risk of cardiac arrhythmias. Invirase and Norvir are protease inhibitors used in combination to treat HIV infection. The study was conducted by Roche, the manufacturer of Invirase, in response to FDA's request that all manufacturers of protease inhibitors evaluate the effect of these drugs on QT and PR ” View full resource at symposier.com
Most Recently Shared on May 24, 2010 at 10:17 pm By:
Symposier Cardiology Cardiology and Health Business
Review of HIV medication Invirase (saquinavir) and Cardiac Arrhythmias. http://bit.ly/9rZAqS
FDA reviews cardiac risk of Invirase in combination with Norvir - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals and patients that it is reviewing clinical trial data about a potentially serious effect on the heart associated with the use of Invirase (saquinavir, from Roche) in combination with Norvir (ritonavir, from Abbott).” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 23, 2010 at 9:09 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA reviews cardiac risk of Invirase in combination with Norvir http://goo.gl/fb/DyEy
FDA Flags Safety Concern for HIV Drug Combination - WSJ.com
online.wsj.com — “The FDA said it was reviewing clinical data that suggest the HIV drug Invirase, given in combination with another HIV drug, Norvir, could cause heart problems.” View full resource at online.wsj.com
Most Recently Shared on February 23, 2010 at 5:47 pm By:
FDA Flags Risks for HIV Drugs http://on.wsj.com/a0Xftg
Advertisement
